All News

Researchers at four European universities are collaborating to develop software that will help encourage the take-up of so called pervasive computing.

European biotech is a hot topic among investors. They have supported as many start-ups as in the US but have seen far from equivalent returns. So what's going on? Science|Business talks to biotechnology consultant John Hodgson.

Open source software has broken the stranglehold of proprietary software vendors. Could the Biological Open Source initiative do the same in biotech?

EU technology policy is moving beyond the numbers game, and getting down to economic basics.

Researchers from Helsinki University have found a way to fight cancer by chewing gum. The gum contains a substance which breaks down carcinogens in the mouth caused by smoking and drinking.

The European Commission wants businesses to spend more on research and development - and to help encourage that, the agency is preparing a volley of government proposals for the Autumn.

Secure Access Solutions, a spin-off from the University of Warwick, has developed a new kind of magnifying lens to help the visually impaired type their pin codes into card readers in shops. It is seeking licensees and investors.

Nanomedicine can be more than a case of adding a trendy label to traditional approaches to pharmaceuticals.

Last week's Innovate2006 conference in Zaragoza included a pre-conference tour of the region with an interesting visit of Endesa and one of the largest Spanish windmill farms, located just a few miles north off Zaragoza.

Yet another consultation is under way into the safety of nanotechnology. This time you have an opportunity to give your views on "the use of nanotechnologies in relation to food".

Intellectual property battles are not always settled in the marketplace. Epic, life-and-death struggles often take place in the judicial arena.

The controversial proposal for a new European Institute of Technology hit more political turbulence, as the EU’s research commissioner questioned whether it should receive preferential funding.

Without access to easy to use analysis tools, patents are becoming an expensive hindrance to many small companies, says Mick McLean, Head of Economics and Public Policy at Scientific Generics.

A cross-continent project to develop fusion as an energy source has moved once step closer to reality with the signing of a formal agreement.

On 8 June the European Commission starts the evaluation of the biofuels technological platform it will support in 2007 - 2013. But the choice will be mired in political treacle.